2012
Managing drug resistance in cancer: lessons from HIV therapy.
Bock C,
Lengauer T.
Nat Rev Cancer. 2012 Jun 7;12(7):494-501.
2012
Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells.
Bieghs V,
Verheyen F,
van Gorp PJ,
Hendrikx T,
Wouters K,
Lütjohann D,
Gijbels MJ,
Febbraio M,
Binder CJ,
Hofker MH,
Shiri-Sverdlov R.
PLoS One. 2012;7(3):e34378. Epub 2012 Mar 28.
2012
LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease.
Bieghs V,
Van Gorp PJ,
Wouters K,
Hendrikx T,
Gijbels MJ,
van Bilsen M,
Bakker J,
Binder CJ,
Lutjohann D,
Staels B,
Hofker MH,
Shiri-Sverdlov R.
PLoS One 7:e30668.
2012
Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice.
Bieghs V,
van Gorp PJ,
Walenbergh SM,
Gijbels MJ,
Verheyen F,
Buurman WA,
Briles DE,
Hofker MH,
Binder CJ,
Shiri-Sverdlov R.
Hepatology. 2012 Sep;56(3):894-903. doi: 10.1002/hep.25660. Epub 2012 Jul 6.
2012
Beta thalassemia major due to acquired uniparental disomy in a previously healthy adolescent.
Bento C,
Maia TM,
Milosevic JD,
Carreira IM,
Kralovics R,
Ribeiro ML.
Haematologica. 2012 Aug 8. [Epub ahead of print].
2012
Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.
Amir S,
Hartvigsen K,
Gonen A,
Leibundgut G,
Que X,
Jensen-Jarolim E,
Wagner O,
Tsimikas S,
Witztum JL,
Binder CJ.
J Lipid Res. 2012 Jul;53(7):1316-26. Epub 2012 Apr 16.
2012
BLUEPRINT to decode the epigenetic signature written in blood.
Adams D,
Altucci L,
Antonarakis SE,
Ballesteros J,
Beck S,
Bird A,
Bock C,
Boehm B,
Campo E,
Caricasole A,
Dahl F,
Dermitzakis ET,
Enver T,
Esteller M,
Estivill X,
Ferguson-Smith A,
Fitzgibbon J,
Flicek P,
Giehl C,
Graf T,
Grosveld F,
Guigo R,
Gut I,
Helin K,
Jarvius J,
Kuppers R,
Lehrach H,
Lengauer T,
Lernmark A,
Leslie D,
Loeffler M,
Macintyre E,
Mai A,
Martens JH,
Minucci S,
Ouwehand WH,
Pelicci PG,
Pendeville H,
Porse B,
Rakyan V,
Reik W,
Schrappe M,
Schubeler D,
Seifert M,
Siebert R,
Simmons D,
Soranzo N,
Spicuglia S,
Stratton M,
Stunnenberg HG,
Tanay A,
Torrents D,
Valencia A,
Vellenga E,
Vingron M,
Walter J,
Willcocks S.
Nat Biotechnol 30, 224-226.
2012
Unraveling the genetic underpinnings of myeloproliferative neoplasm and understanding their effect on disease course and response to therapy: proceedings from the 6th International Post-ASH Symposium.
Abdel-Wahab O,
Pardanani A,
Bernard OA,
Finazzi G,
Crispino JD,
Gisslinger H,
Kralovics R,
Odenike O,
Bhalla K,
Gupta V,
Barosi G,
Gotlib J,
Guglielmelli P,
Kiladjian JJ,
Noel P,
Cazzola M,
Vannucchi AM,
Hoffman R,
Barbui T,
Thiele J,
Van Etten RA,
Mughal T,
Tefferi A.
Am J Hematol. 2012 May;87(5):562-8. doi: 10.1002/ajh.23169. Epub 2012 Mar 28.
2012
A Novel Mutation in the Complement Component 3 Gene in a Patient with Selective IgA Deficiency.
Santos-Valente E,
Reisli I,
Artaç H,
Ott R,
Sanal O,
Boztug K.
J Clin Immunol. 2013 Jan;33(1):127-33. doi: 10.1007/s10875-012-9775-z. Epub 2012 Sep 21.
2012
Combined immunodeficiency with life-threatening EBV-associatedlymphoproliferative disorder in patients lacking functional CD27.
Salzer E,
Daschkey S,
Choo S,
Gombert M,
Santos-Valente E,
Ginzel S,
Schwendinger M,
Haas OA,
Fritsch G,
Pickl WF,
Foerster-Waldl E,
Borkhardt A,
Boztug K*,
Bienemann K*,
Seidel MG*.
Haematologica. 2013 Mar;98(3):473-8. doi: 10.3324/haematol.2012.068791. Epub 2012 Jul 16. (*equal contributing authors)
